These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 19278989
1. PGE2 production in oral cancer cell lines is COX-2-dependent. Husvik C, Khuu C, Bryne M, Halstensen TS. J Dent Res; 2009 Feb; 88(2):164-9. PubMed ID: 19278989 [Abstract] [Full Text] [Related]
2. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. Minter HA, Eveson JW, Huntley S, Elder DJ, Hague A. Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747 [Abstract] [Full Text] [Related]
3. Prostaglandin E(2) pathway in head and neck squamous cell carcinoma. Camacho M, León X, Fernández-Figueras MT, Quer M, Vila L. Head Neck; 2008 Sep; 30(9):1175-81. PubMed ID: 18642283 [Abstract] [Full Text] [Related]
4. Piroxicam inhibits Masitinib-induced cyclooxygenase 2 expression in oral squamous cell carcinoma cells in vitro. Rathore K, Alexander M, Cekanova M. Transl Res; 2014 Aug; 164(2):158-68. PubMed ID: 24631063 [Abstract] [Full Text] [Related]
5. Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion. Nystrom ML, McCulloch D, Weinreb PH, Violette SM, Speight PM, Marshall JF, Hart IR, Thomas GJ. Cancer Res; 2006 Nov 15; 66(22):10833-42. PubMed ID: 17108119 [Abstract] [Full Text] [Related]
6. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells. Liu CY, Lai YY, Lo CJ. J Surg Res; 2004 Apr 15; 117(2):223-31. PubMed ID: 15047127 [Abstract] [Full Text] [Related]
7. Factors predicting outcome after salvage treatment for stage IV oral squamous cell carcinoma: Evidence of the potential importance of the cyclooxygenase-2-prostaglandin E2 pathway. Kekatpure VD, Singh M, Selvam S, Shetkar G, Hedne NC, Trivedi NP, Siddappa G, Govindan SV, Suresh A, Rangarajan B, Dannenberg AJ, Kuriakose MA. Head Neck; 2015 Aug 15; 37(8):1142-9. PubMed ID: 24771596 [Abstract] [Full Text] [Related]
13. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway. Yasumaru M, Tsuji S, Tsujii M, Irie T, Komori M, Kimura A, Nishida T, Kakiuchi Y, Kawai N, Murata H, Horimoto M, Sasaki Y, Hayashi N, Kawano S, Hori M. Cancer Res; 2003 Oct 15; 63(20):6726-34. PubMed ID: 14583467 [Abstract] [Full Text] [Related]
14. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Zweifel BS, Davis TW, Ornberg RL, Masferrer JL. Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270 [Abstract] [Full Text] [Related]
17. Involvement of cyclooxygenase-2 in interleukin-1alpha-induced prostaglandin production by human periodontal ligament cells. Noguchi K, Shitashige M, Ishikawa I. J Periodontol; 1999 Aug 15; 70(8):902-8. PubMed ID: 10476899 [Abstract] [Full Text] [Related]